Local News

Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per…

Traditionally, scientists have studied immune system diseases by looking at blood samples. But they’ve also…

The “summary” section of Jesse Gray’s resume is short and understated: “I build teams to…

Working under the direction of BBI’s Danny Miller, M.D., Ph.D., three graduate students, along with…

Researchers opened the doors Monday to the new Seattle Hub for Synthetic Biology, a collaboration…

ProfoundBio, a Seattle-based biotech firm developing drugs to treat ovarian and endometrial cancers, will be…

Gretchen Schoenstein achieved an extraordinary feat completing two half marathons on opposite coasts in two…

Dr. Charles “Chuck” Murry, the director of the Institute for Stem Cell and Regenerative Medicine…

In the human brain, billions of neurons transmit unfathomable amounts of information across an elaborate…

Sonoma Biotherapeutics on Monday hosted a ribbon cutting ceremony at its new research and development…